3648 results for «2573»
3648 results
Unusual clinical cases: thinking beyond the routine
22 May 2026 – From EuroPCR 2026
This session presents unusual and challenging clinical cases that extend beyond routine interventional cardiology. From optimised in-stent restenosis treatment to rare anatomical anomalies and complex thrombus management, it offers valuable lessons in creative problem-solving and advanced intervention techniques.
Left main PCI
21 May 2026 – From EuroPCR 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) involving the left main coronary artery. It features challenging clinical cases including acute total occlusion with cardiogenic shock, innovative techniques like the inverted Double TAP for trifurcations, mechanical circulatory support integration, management of stent complications, and...
Management of uncommon TAVI complications
21 May 2026 – From EuroPCR 2026
This session delves into the management of uncommon but critical complications arising from Transcatheter Aortic Valve Implantation (TAVI). Through detailed case studies from Italy, Lebanon, and Turkey, it highlights real-time decision-making strategies for life-threatening scenarios including left ventricular outflow tract obstruction, acute aortic dissection, and complex...
TAVI procedural challenges
21 May 2026 – From EuroPCR 2026
This session examines procedural challenges encountered during Transcatheter Aortic Valve Implantation (TAVI), especially in complex anatomical and clinical contexts. Topics include TAVI after prior mitral valve procedures, combined use of left ventricular assist devices and rotablation, navigating challenging aortic anatomies, and managing extensive calcification. The session...
Imaging-guided CTO PCI
21 May 2026 – From EuroPCR 2026
This session focuses on imaging-guided CTO PCI, presenting cases that illustrate the utility of OCT, CT, and IVUS for lesion assessment and procedural guidance. Topics include woven-like CTOs, double CTO evaluation, management of late stent malapposition, and strategies for navigating complex occlusions to optimize outcomes.
Incorporating CT coronary angiography in the cathlab practice
21 May 2026 – From EuroPCR 2026
Explore the integration of CT coronary angiography into catheterization laboratory practice through real-world studies assessing anatomical yield, diagnostic accuracy, and physiological assessments. The session highlights advancements in myocardial blood flow analysis and plaque characterization to improve ischemia detection and guide invasive angiography.
Post myocardial infarction and iatrogenic VSDs: case-based decision taking
21 May 2026 – From EuroPCR 2026
This session focuses on decision-making in post-myocardial infarction and iatrogenic ventricular septal defects (VSDs) through illustrative cases. It covers transcatheter closure techniques, zero contrast interventions guided by echocardiography, and innovative approaches to late and residual VSDs following congenital heart surgery.
Novel indications for DCB
21 May 2026 – From EuroPCR 2026
This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.
Challenging clinical scenarios in STEMI
21 May 2026 – From EuroPCR 2026
This session explores challenging clinical scenarios in STEMI, including coronary embolisation from aortic valve vegetation, blunt chest trauma-related STEMI, intramural hematoma diagnostics with multimodality imaging, acute stent thrombosis during dengue recovery, and advanced clot removal techniques beyond standard aspiration devices.
TAVI in small annuli - Small anatomies, big challenges
21 May 2026 – From EuroPCR 2026
This session addresses the challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. It features registry data comparing valve types, evaluates long-term outcomes, prosthesis-patient mismatch implications, and regional variations in clinical and quality-of-life outcomes.
CTO ADVANCED Level III: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland
21 May 2026 – From EuroPCR 2026
This advanced educational session features live complex chronic total occlusion (CTO) PCI cases from Institut Cardiovasculaire Paris Sud and University Hospital Basel. It emphasizes optimizing strategy selection, procedural efficiency across diverse CTO anatomies, and integrating advanced techniques into routine complex practice.
Physiological vs. anatomical assessment of multivessel disease patients
21 May 2026 – From EuroPCR 2026
This session delves into the comparative benefits of physiological versus anatomical assessment in patients with multivessel coronary disease, focusing particularly on myocardial infarction cases. Attendees will explore how coronary physiology can guide complete revascularisation, the added value of physiological assessment beyond conventional angiography, and the selection...
Left main PCI: technical limits
21 May 2026 – From EuroPCR 2026
This comprehensive session reviews the technical challenges and current strategies in left main PCI. Topics include provisional versus DK crush approaches, IVUS-based assessment of ostial LAD lesions, long-term outcomes of DCB use in left main bifurcations, stenting strategies for complex lesions, and the prognostic value of...
Refining PCI plannings and decision-making with novel technologies
21 May 2026 – From EuroPCR 2026
This session highlights cutting-edge technologies that enhance PCI planning and decision-making. It covers the clinical populations benefiting from QFR-guided revascularisation, prognostic insights from radial wall strain in DCB-treated vessels, and advances in artificial intelligence and machine learning to assess ischemia and predict PCI outcomes, especially in...
Mitral interventions: procedural risk assessment and interventions
21 May 2026 – From EuroPCR 2026
Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.
Advancing TAVI practice
21 May 2026 – From EuroPCR 2026
Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.
Ambiguous left main lesions: how to assess severity and make the right decision
21 May 2026 – From EuroPCR 2026
Addressing the complexities of ambiguous left main coronary lesions, this session elucidates the integration of physiology, intracoronary imaging, and CT scanning for comprehensive assessment. It highlights multimodality diagnostic strategies and decision-making frameworks to guide appropriate revascularization.
TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.
Inflammation and cardiovascular risk
21 May 2026 – From EuroPCR 2026
Exploring the interplay between inflammation and cardiovascular risk, this session reviews contemporary research on residual risk post-PCI, inflammatory markers in coronary artery disease especially in type 2 diabetes and ACS, and prognostic tools including lipoprotein(a) and systemic inflammation indices.
TAVI - Procedural strategy
21 May 2026 – From EuroPCR 2026
This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in...
